Clinical Trial Update: Novel Smoking Cessation Drug for Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial update for a novel smoking cessation drug studied in schizophrenia, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Smoking Cessation

Drugs mentioned

• Novel Smoking Cessation Drug

Snippet

Sponsor: K.N. Roy Chengappa | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2018-01-30